Select a year:
Select a category:

4 questions au professeur Guillaume Canaud

 En tant que scientifique, associez-vous un ou des objectifs spécifiques à votre activité de recherche ? Si oui lequel ou lesquels ? Pr. Canaud: Oui effectivement, je me pose, ou plutôt nous nous posons car il s’agit d’un travail d’équipe, deux questions clés :  1-Comment cela fonctionne-t-il ?  2-Comment utiliser nos connaissances pour améliorer la vie des&hellip

Read More

4P-PHARMA IN “SMART MORNING SOUMIER”

Revital Rattenbach, 4P-Pharma’s chairwoman has been interviewed by Stéphane Soumier in “Smart Morning Soumier”. The program is broadcasted on June 30th, 2022, on B SMART TV and RTL. ​ For more information: click here 

Read More

4P-Pharma and Delta 4 join forces to find and develop treatments for a rare autoimmune chronic liver disease

4P-Pharma and Delta 4, an Austrian digital drug development company, today announce the signing of a collaboration agreement. Under this agreement, both companies will jointly identify and develop first-in-class drug candidates for a rare autoimmune chronic liver disease for which currently no effective curative treatment is available.​ Kurt Herpel, CEO of Delta4 commented that “We are looking forward to&hellip

Read More

4P-Pharma at BIO 2022

4P-Pharma will attend the upcoming BIO2022, in San Diego (US), June 13-16.​ Revital Rattenbach, our chairwoman, Roselina Lam, our business development and licensing-in manager are glad to attend the event, as part of the Business France delegation.​ To learn more about us, our pipeline and discuss future partnership, please feel free to connect with us via the partnering platform or by e-mail.​​ We are&hellip

Read More